Common Stock, Shares, Outstanding of G1 Therapeutics, Inc. from 31 Dec 2016 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
G1 Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Jun 2024.
  • G1 Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 52,697,879, a 1.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

G1 Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 52,697,879 +989,432 +1.9% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 52,234,385 +575,088 +1.1% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 51,926,075 +426,641 +0.83% 31 Dec 2023 10-Q 08 Aug 2024 2024 Q2
Q3 2023 51,809,878 +8,912,797 +21% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 51,708,447 +8,980,970 +21% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 51,659,297 +8,953,765 +21% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 51,499,434 +8,937,286 +21% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 42,897,081 +374,933 +0.88% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 42,727,477 +481,156 +1.1% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 42,705,532 +689,558 +1.6% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 42,562,148 +4,448,058 +12% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 42,522,148 +4,492,213 +12% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 42,246,321 +4,333,921 +11% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 42,015,974 +4,278,714 +11% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 38,114,090 +502,496 +1.3% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 38,029,935 +448,423 +1.2% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 37,912,400 +408,459 +1.1% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 37,737,260 +276,244 +0.74% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 37,611,594 +369,468 +0.99% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 37,581,512 +442,209 +1.2% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 37,503,941 +4,426,176 +13% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 37,461,016 +4,776,131 +15% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 37,242,126 +8,848,281 +31% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 37,139,303 +8,796,290 +31% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 33,077,765 +4,792,287 +17% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 32,684,885 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 28,393,845 +26,915,564 +1821% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 28,343,013 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 28,285,478 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q4 2016 1,478,281 31 Dec 2016 10-K 21 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.